Overexpression of USP3 promoted cells resistant to docetaxel treatment and SMARCA5 silencing in both PCa cells resensitized cells to docetaxel in USP3 overexpressed cells (Fig. 6C, D). The gene discussed is SMARCA5; the disease is posterior cortical atrophy.